Lamotrigine reduces voltage-gated sodium currents in rat central neurons in culture

被引:54
作者
Zona, C
Avoli, M
机构
[1] MCGILL UNIV,MONTREAL NEUROL INST,RES GRP CELL BIOL EXCITABLE TISSUE,MONTREAL,PQ H3A 2B4,CANADA
[2] MCGILL UNIV,DEPT NEUROL & NEUROSURG,MONTREAL,PQ,CANADA
[3] MCGILL UNIV,DEPT PHYSIOL,MONTREAL,PQ,CANADA
[4] UNIV ROMA TOR VERGATA,DIPARTIMENTO MED SPERIMENTALE & SCI BIOCHIM,ROME,ITALY
关键词
lamotrigine; antiepileptic drugs; sodium currents; rat; granule cells;
D O I
10.1111/j.1528-1157.1997.tb01135.x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Purpose: To study the mechanism or mechanisms of action of lamotrigine (LTG) and, in particular, to establish its effects on the function of NA(+) channels in mammalian central neurons. Methods: Rat cerebellar granule cells in culture were subjected to the whole-cell mode of voltage clamping under experimental conditions designed to study voltage-gated Na+ currents. Results: Extracellular application of LTG (10-500 mu M, n = 21) decreased in a dose-related manner a tetrodotoxin-sensitive inward current that was elicited by depolarizing commands (from -80 to +20mV). The peak amplitude of this Na+-mediated current was diminished by 38.8 +/- 12.2% (mean +/- SD, n = 6) during application of 100 mu M LTG, and the dose-response curve of this effect indicated an IC50 of 145 mu M. The reduction in the inward currents produced by LTG was not associate with any significant change in the current decay, whereas the voltage dependency of the steady-state inactivation shifted toward more negative values (midpoint of the inactivation curve: -47.5 and -59.0 mV under control conditions and during application of 100 mu M LTG, respectively, n = 4). Conclusions: Our findings indicate that LTG reduces the amplitude of voltage-gated Na+ inward current in rat cerebellar granule cells and induces a negative shift of the steady-state inactivation curve. Both mechanisms may be instrumental in controlling the repetitive firing of action potentials (AP) that occurs in neuronal networks during seizure activity.
引用
收藏
页码:522 / 525
页数:4
相关论文
共 15 条
[1]   DOUBLE-BLIND CROSSOVER TRIAL OF LAMOTRIGINE (LAMICTAL) AS ADD-ON THERAPY IN INTRACTABLE EPILEPSY [J].
BINNIE, CD ;
DEBETS, RMC ;
ENGELSMAN, M ;
MEIJER, JWA ;
MEINARDI, H ;
OVERWEG, J ;
PECK, AW ;
VANWIERINGEN, A ;
YUEN, WC .
EPILEPSY RESEARCH, 1989, 4 (03) :222-229
[2]  
CHEUNG H, 1992, EPILEPSY RES, V13, P107
[3]   ELECTRO-PHYSIOLOGICAL PROPERTIES OF NEOCORTICAL NEURONS INVITRO [J].
CONNORS, BW ;
GUTNICK, MJ ;
PRINCE, DA .
JOURNAL OF NEUROPHYSIOLOGY, 1982, 48 (06) :1302-1320
[4]  
LANG DG, 1993, J PHARMACOL EXP THER, V266, P829
[5]  
Leach Michael J., 1995, P861
[6]   STUDIES ON THE MECHANISM OF ACTION OF THE NOVEL ANTICONVULSANT LAMOTRIGINE (LAMICTAL) USING PRIMARY NEUROGLIAL CULTURES FROM RAT CORTEX [J].
LEES, G ;
LEACH, MJ .
BRAIN RESEARCH, 1993, 612 (1-2) :190-199
[7]   PLACEBO-CONTROLLED STUDY OF THE EFFICACY AND SAFETY OF LAMOTRIGINE IN PATIENTS WITH PARTIAL SEIZURES [J].
MATSUO, F ;
BERGEN, D ;
FAUGHT, E ;
MESSENHEIMER, JA ;
DREN, AT ;
RUDD, GD ;
LINEBERRY, CG ;
MADSEN, JA ;
RISTANOVIC, R ;
ERENBERG, G ;
KRAMER, RE ;
HARNER, RN ;
SCHOMER, DL ;
LEPPIK, I ;
COLLINS, SD ;
KING, KW ;
SHAMSNIA, M ;
WHITE, RL ;
GAY, PE ;
ROTHNER, AD ;
DRAKE, ME ;
DETOLEDO, J ;
SUSSMAN, NM ;
MIKATI, MA ;
OLSON, D ;
FROMM, G ;
MURRO, AM ;
EHLE, A ;
FOLEY, JF ;
MORRIS, HH ;
SMITH, DB ;
SO, EL ;
SCHACHTER, SC ;
KUZNIECKY, R ;
LAXER, K ;
GALLAGHER, BB ;
WEISBERG, LA ;
MOORE, EL .
NEUROLOGY, 1993, 43 (11) :2284-2291
[8]   MEMBRANE-PROPERTIES OF RAT SUBICULAR NEURONS IN-VITRO [J].
MATTIA, D ;
HWA, GGC ;
AVOLI, M .
JOURNAL OF NEUROPHYSIOLOGY, 1993, 70 (03) :1244-1248
[9]  
MCLEAN MJ, 1986, J PHARMACOL EXP THER, V237, P1001
[10]   PHARMACOLOGICAL STUDIES ON LAMOTRIGINE, A NOVEL POTENTIAL ANTIEPILEPTIC DRUG .1. ANTICONVULSANT PROFILE IN MICE AND RATS [J].
MILLER, AA ;
WHEATLEY, P ;
SAWYER, DA ;
BAXTER, MG ;
ROTH, B .
EPILEPSIA, 1986, 27 (05) :483-489